Open AccessThe use of autologous serum eye drops for the treatment of ocular surface disorders
Author(s) -
Estela García-Martín,
Sagrario Pernía-López,
RM Romero Jiménez,
Blanca García-Valcárcel,
Pilar A Martínez-Ortega,
María SanjurjoSáez
Publication year - 2018
Publication title -
european journal of hospital pharmacy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.313
H-Index - 14
eISSN - 2047-9964
pISSN - 2047-9956
DOI - 10.1136/ejhpharm-2018-001527
Subject(s) - medicine , blepharitis , blepharospasm , medical prescription , ophthalmology , retrospective cohort study , adverse effect , dosing , eye care , corneal ulcer , cornea , eye drop , surgery , dermatology , optometry , botulinum toxin , pharmacology
To investigate the use of autologous serum (AS) eye drops in patients with ocular surface disorders who were refractory to conventional treatments.